Skip to main content
38°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PMGC Holdings Inc.
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
March 10, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
March 06, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
February 27, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
February 26, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
February 18, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
February 04, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies
January 31, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
January 30, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors
January 27, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium
January 24, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture
January 16, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
January 15, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
January 02, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
ELAB
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
January 02, 2025
From
PMGC Holdings Inc.
Via
GlobeNewswire
Tickers
CTCX
ELAB
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.